How AI is revolutionizing early cancer detection

When Michelle Aquilina became CEO of MoleMap Australia and New Zealand, the company was in financial distress and lacked a clear identity. Today, it's a global leader in skin cancer detection, combining clinical expertise with proprietary AI technology that achieves 95 percent accuracy. In this episode, Aquilina discusses the boldness required to take the first steps with AI technology, why human clinicians will never be replaced in healthcare and how she led her team through integrating Kāhu AI into clinical workflows without resistance. This conversation reveals what courageous leadership looks like in practice.    Access our free digital content: https://digitalmag.theceomagazine.com   Follow us:   LinkedIn: @the-ceo-magazine-global   Facebook: @theceomagazineglobal   X: @ceomagazinegl  Instagram: @theceomagazineglobal     Follow Michelle Aquilina and MoleMap: LinkedIn: https://www.linkedin.com/in/michelle-aquilina-emba-44852727 Website: https://www.molemap.net.au/See omnystudio.com/listener for privacy information.

There are no comments yet.

Please log in to write the first comment.